Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Israeli medical imaging firm Nanox raises 26 million dollars

      Israeli medical imaging firm Nanox raises 26 million dollars

      Medical Dialogues Bureau18 Jan 2020 11:59 AM IST
      Tel Aviv: Israeli medical imaging company Nanox Imaging Ltd said on Thursday it raised $26 million with the participation of strategic investor...
      Metropolis Healthcare signs binding agreement to buy Shraddha Diagnostics

      Metropolis Healthcare signs binding agreement to buy Shraddha Diagnostics

      Medical Dialogues Bureau18 Jan 2020 11:37 AM IST
      New Delhi: Pan-India pathology specialist chain Metropolis Healthcare Ltd. has signed a binding agreement to acquire Ahmedabad-based Shraddha...
      Novo Nordisks Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and established CVD

      Novo Nordisk's Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and established CVD

      Medical Dialogues Bureau18 Jan 2020 10:36 AM IST
      Denmark: Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved a label expansion based on a supplemental New...
      Wockhardt gets DCGI nod for 2 new antibiotics

      Wockhardt gets DCGI nod for 2 new antibiotics

      Medical Dialogues Bureau17 Jan 2020 1:57 PM IST
      'DCGI has approved Wockhardts 2 new antibiotics, EMROK (IV) and EMROK O (Oral), for acute bacterial skin and skin structure Infections including...
      Group B Streptococcus: Hilleman Labs announces to make affordable vaccine

      Group B Streptococcus: Hilleman Labs announces to make affordable vaccine

      Medical Dialogues Bureau17 Jan 2020 1:27 PM IST
      New Delhi:: In a bid to strengthen its vaccine portfolio and expand into areas of unmet need, Hilleman Laboratories, a global research and development...
      Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO

      Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO

      Medical Dialogues Bureau17 Jan 2020 12:45 PM IST
      San Francisco: Eli Lilly and Co aim to announce roughly one $1 billion (765 million pounds) to $5 billion (3.8 billion pounds) deal every quarter in...
      Govt may impose anti-dumping duty on pharma chemical from China, Saudi Arabia

      Govt may impose anti-dumping duty on pharma chemical from China, Saudi Arabia

      Medical Dialogues Bureau17 Jan 2020 12:00 PM IST
      New Delhi: The government may impose anti-dumping duty on a chemical used in pharma and pesticide industries from China and Saudi Arabia with a view...
      AstraZeneca to end heart drug Epanova trial, expects USD 100 million writedown

      AstraZeneca to end heart drug Epanova trial, expects USD 100 million writedown

      Medical Dialogues Bureau14 Jan 2020 9:15 AM IST
      AstraZeneca said the decision, which followed recommendations from an independent data monitoring committee, was due to low likelihood of the drug's...
      Pharma firm founder, former employees face reckoning in opioid bribery case

      Pharma firm founder, former employees face reckoning in opioid bribery case

      Medical Dialogues Bureau14 Jan 2020 9:00 AM IST
      The case against Insys Therapeutics' founder John Kapoor and his associates was considered the first that sought to hold an opioid maker and its...
      Lupin gets 2 observations from USFDA for Nagpur facility

      Lupin gets 2 observations from USFDA for Nagpur facility

      Medical Dialogues Bureau13 Jan 2020 11:58 AM IST
      Drug firm Lupin on Saturday said it has received two observations from the US health regulator following the inspection of its Nagpur manufacturing...
      Biocon Biologics appoints M B Chinappa as Chief Financial Officer

      Biocon Biologics appoints M B Chinappa as Chief Financial Officer

      Medical Dialogues Bureau12 Jan 2020 9:32 AM IST
      M B Chinappa joins Biocon Biologics from Biocon’s subsidiary company Syngene International Ltd, where he was President (Finance) and CFO since 2008....
      Bayer, Evotec collaborate to develop multiple clinical candidates to treat PCOS

      Bayer, Evotec collaborate to develop multiple clinical candidates to treat PCOS

      Medical Dialogues Bureau11 Jan 2020 9:15 AM IST
      Under the terms of the agreement, Bayer and Evotec will contribute the drug targets and a comprehensive set of high-quality technology platforms to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok